{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:04:15Z","timestamp":1793189055587,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017804","name":"City of Hope","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.03.024","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:21:58Z","timestamp":1774714918000},"page":"877.e1-877.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"given":"Jorge M. Ramos","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leana","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Uranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslava","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Aldoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoroenyi","family":"Amanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-9607","authenticated-orcid":false,"given":"Shukaib","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Blackmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-9463","authenticated-orcid":false,"given":"Pamela","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmon","family":"Otoukesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3862-4612","authenticated-orcid":false,"given":"Hoda","family":"Pourhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Pullarkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-8484","authenticated-orcid":false,"given":"Karamjeet S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Spielberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8674-9394","authenticated-orcid":false,"given":"William","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-5046","authenticated-orcid":false,"given":"Eileen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monzr M. Al","family":"Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-9607","authenticated-orcid":false,"given":"Andrew S.","family":"Artz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.03.024_bib0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/blood-2023-179457","article-title":"Age-related differences in utilization of allogeneic HCT for acute myeloid leukemia in California: results of a population-based, novel linked dataset","volume":"142","author":"Meyer","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.03.024_bib0002","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.bbmt.2019.12.115","article-title":"Transplant physicians\u2019 attitudes on candidacy for allogeneic hematopoietic cell transplantation (HCT) in older patients: the need for a standardized geriatric assessment (GA) tool","volume":"26","author":"Mishra","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.03.024_bib0003","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/s41375-019-0477-x","article-title":"Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study","volume":"33","author":"Ustun","year":"2019","journal-title":"Leukemia"},{"issue":"30","key":"10.1016\/j.jtct.2026.03.024_bib0004","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.20.03380","article-title":"Biologic assignment trial of reduced-intensity hematopoietic cell transplantation based on donor availability in patients 50-75 years of age with advanced myelodysplastic syndrome","volume":"39","author":"Nakamura","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2026.03.024_bib0005","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/bloodadvances.2019001084","article-title":"Survival following allogeneic transplant in patients with myelofibrosis","volume":"4","author":"Gowin","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jtct.2026.03.024_bib0006","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.jtct.2023.04.011","article-title":"Transplantation referral patterns for patients with newly diagnosed higher-risk myelodysplastic syndromes and acute myeloid leukemia at academic and community sites in the Connect(R) myeloid disease registry: potential barriers to care","volume":"29","author":"Tomlinson","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.03.024_bib0007","first-page":"68","article-title":"Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study","volume":"110","author":"Niederwieser","year":"2025","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2026.03.024_bib0008","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Non-ablative versus reduced intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"De Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.024_bib0009","doi-asserted-by":"crossref","unstructured":"Cusatis R., Litovich C., Feng Z., Allbee-Johnson M., Kapfhammer M., Mattila D., Akinola I., Phelan R., Broglie L.A., Auletta J.J., Steinert P., Bolon Y., Akhtar O., Bloomquist J., Chen M., Devine S.M., Bupp C., Hamadani M., Hengen M., Jaglowski S., Kaur M., Kuxhausen M., Lee S.J., Moskop A., Page K.M., Pasquini M.C., Rizzo D., Saber W., Spellman S.R., Stefanski H.E., Tuschl E., Yusuf R., Zhan K., Flynn K.E., Shaw B.E. Current trends and outcomes in cellular therapy activity in the United States, including prospective patient-reported outcomes data collection in the Center for International Blood and Marrow Transplant Research registry. Transplant Cell Ther. 2024 Sep 1; 30(9):917.e1-917.e12. doi:10.1016\/j.jtct.2024.06.021.","DOI":"10.1016\/j.jtct.2024.06.021"},{"issue":"29","key":"10.1016\/j.jtct.2026.03.024_bib0010","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2026.03.024_bib0011","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41409-022-01650-5","article-title":"Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis","volume":"57","author":"Maakaron","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.03.024_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbmt.2016.09.027","article-title":"Allogeneic stem cell transplantation for patients age >\/= 70 years with myelodysplastic syndrome: a retrospective study of the MDS subcommittee of the chronic malignancies working party of the EBMT","volume":"23","author":"Heidenreich","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.03.024_bib0013","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jtct.2026.03.024_bib0014","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jtct.2026.03.024_bib0015","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1078-0432.CCR-23-3673","article-title":"Improvements in posttransplant outcomes over two decades in older patients with acute myeloid leukemia in the EBMT ALWP study","volume":"30","author":"Bazarbachi","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"13","key":"10.1016\/j.jtct.2026.03.024_bib0016","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/bloodadvances.2019001266","article-title":"Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report","volume":"4","author":"Zhou","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.03.024_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","article-title":"Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care","volume":"59","author":"Fried","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"16","key":"10.1016\/j.jtct.2026.03.024_bib0018","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2026.03.024_bib0019","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jamaneurol.2017.2802","article-title":"Disability trajectories before and after stroke and myocardial infarction: the cardiovascular health study","volume":"74","author":"Dhamoon","year":"2017","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.jtct.2026.03.024_bib0020","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/bloodadvances.2019000155","article-title":"Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70","volume":"3","author":"Imus","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.03.024_bib0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/bloodadvances.2018028241","article-title":"Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults","volume":"3","author":"Lin","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2026.03.024_bib0022","doi-asserted-by":"crossref","first-page":"309.e1","DOI":"10.1016\/j.jtct.2022.02.022","article-title":"Patterns and predictors of functional decline after allogeneic hematopoietic cell transplantation in older adults","volume":"28","author":"Huang","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2026.03.024_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgo.2021.08.008","article-title":"Serial frailty assessments following allogeneic stem cell transplant in older adults: a pilot study","volume":"13","author":"Ombres","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2026.03.024_bib0024","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1016\/j.jtct.2026.03.024_bib0025","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2026.03.024_bib0026","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","article-title":"A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens","volume":"115","author":"Rodriguez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.03.024_bib0027","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of $K$-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist"},{"issue":"23","key":"10.1016\/j.jtct.2026.03.024_bib0028","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jtct.2026.03.024_bib0029","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1200\/JCO.23.02536","article-title":"Prevalence and cancer-specific patterns of functional disability among US cancer survivors, 2017-2022","volume":"42","author":"Cao","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2026.03.024_bib0030","first-page":"qxaf184","article-title":"From 4Ms to 5 domains: ensuring new CMS age-friendly hospital measure improves care for older adults","volume":"3","author":"Adler-Milstein","year":"2025","journal-title":"Health Aff Sch"},{"issue":"1","key":"10.1016\/j.jtct.2026.03.024_bib0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/bloodadvances.2018028241","article-title":"Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults","volume":"3","author":"Lin","year":"2019","journal-title":"Blood Advances"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.03.024_bib0032","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood-2024-194414","article-title":"The Composite Health Risk Assessment Model (CHARM) predicts risks of toxicities, functional and cognitive decline among survivors of allogeneic hematopoietic cell transplantation (allo-HCT): a prospective BMT-CTN Study 1704","volume":"144","author":"Sorror","year":"2024","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2026.03.024_bib0033","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/oxfordjournals.aje.a010088","article-title":"Do elderly women have more physical disability than men do?","volume":"150","author":"Oman","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"13","key":"10.1016\/j.jtct.2026.03.024_bib0034","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2025015793","article-title":"Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704","volume":"9","author":"Sorror","year":"2025","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.jtct.2026.03.024_bib0036","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-Transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bolanos-Meade","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:59:27Z","timestamp":1782745167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726002332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666636726002332"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.024","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}